Infectious disease Archives

stephanie bewick destiny pharma chief business officer

Expert Advice 2 May 2022

Chief Business Officers: Shedding Light on Biotech’s Dealmakers

In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business Officer maximizes their company’s commercial appeal and lands deals in the biotech industry. Stephanie Bewick began her career as an academic researcher before spending more […]

May 2, 2022 - 5 minutesmins - By Victor Kotsev

world health organization genomics pathogen pandemic

News and Trends 5 Apr 2022

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

The World Health Organization has released a 10-year plan to monitor the genetic make-up of pathogens across the globe. The strategy highlights how far genomics has come during the Covid-19 pandemic and how far there is to go. The past two years have seen unprecedented global collaboration as researchers raced to better understand the epidemiology, […]

April 5, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments and vaccines are hitting the late-stage pipeline, which could greatly expand the anti-Covid-19 arsenal. Two years ago, the Covid-19 pandemic swept the world and left economic disruption, healthcare crises, and widespread lockdowns in its wake. […]

February 15, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 10 Feb 2022

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

An international academic team has made strides in carrying out genome sequencing faster and more cheaply in low- and middle- income nations. This could improve the control of potentially lethal salmonella infections and propel research into vaccines. As the price of DNA sequencing continues to fall, genomics and bioinformatics firms are drawing ever more attention […]

February 10, 2022 - 6 minutesmins - By Jonathan Smith

January Financial Top European Investments

News and Trends 3 Feb 2022

The Top European Biotech Investments in January 2022

Viral infection treatments, cell therapy, and artificial intelligence led biotech investments in January 2022 as the European sector took a collective breather from December’s funding frenzy. European biotech investments started 2022 at a modest level compared to the huge cash flow seen in November and December 2021. While December 2021 saw almost €1.6B money raised, […]

February 3, 2022 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M Series B round, the German firm Ethris is riding the mRNA buzz by developing inhalable mRNA therapies for respiratory diseases. As Covid-19 mRNA vaccines entered the market for the first time in 2020, the wide potential of mRNA technology became […]

February 1, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Jan 2022

French Project to Tackle Antibiotic Resistance with Biotech and Economics

A team of French organizations led by the biotech firm Antabio has launched a €17M project to deploy therapeutic, diagnostic, and economic innovations in the battle against antibiotic resistance. The project, dubbed ARPEGE, involves four partners covering a variety of disciplines: the antibiotics developer Antabio; the diagnostics heavyweight bioMérieux; the university hospital group Hospices Civils […]

January 7, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 25 Nov 2021

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with vaccines often in the spotlight, treatment options available to doctors remain few. Earlier this month, the European Commission gave its stamp of approval to two antibody treatments for Covid-19: regdanvimab from the South Korean firm Celltrion Healthcare, and a blend […]

November 25, 2021 - 6 minutesmins - By Victor Kotsev

antibiotic resistance investment funding amr

News and Trends 21 Sep 2021

Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms

Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained flat. However, growing regulatory and societal awareness could spell fresh investments in the coming years. Over the last decade, pressure has been mounting on healthcare systems as infectious microbes become harder and harder to fight with antibiotics. Some strains of […]

September 21, 2021 - 7 minutesmins - By Jonathan Smith

In Depth 6 Sep 2021

Why We Desperately Need to Develop New Antifungals

While serious fungal infections are rare, there is a limited number of approved drugs to treat them, and they may not always work due to the rise of antimicrobial resistance. Despite the challenges, researchers are starting to add new weapons to the arsenal to protect us against these microscopic invaders. Developing effective antifungals is a […]

September 6, 2021 - 10 minutesmins - By Helen Albert

Chikungunya vaccine clinical trial Valneva

News and Trends 19 Aug 2021

Chikungunya Vaccine First to Succeed in Phase III Trial

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya may become preventable with a new vaccine candidate from French biotech Valneva that just passed phase III trials. The results of the phase III trial revealed that a single dose of the live attenuated vaccine developed by Valneva induced the […]

August 19, 2021 - 3 minutesmins - By Victor Kotsev

News and Trends 17 Aug 2021

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are interested in messenger RNA technologies beyond Covid-19. Based in Boston, US, Translate Bio develops mRNA therapies for a range of conditions, including respiratory, liver, and infectious diseases. The company’s €2.7B ($3.2B) buyout, announced by Sanofi earlier this month, seems a […]

August 17, 2021 - 5 minutesmins - By Mark Zipkin

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Infectious disease

Chief Business Officers: Shedding Light on Biotech’s Dealmakers

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

The Top European Biotech Investments in January 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

French Project to Tackle Antibiotic Resistance with Biotech and Economics

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms

Why We Desperately Need to Develop New Antifungals

Chikungunya Vaccine First to Succeed in Phase III Trial

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!